Xuelin Huang

ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 41

Top Venues

Statistics in medicine

Molecular cancer therapeutics

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Blood advances

University of Texas M D Anderson Cancer Center Department of Biostatistics

University of Michigan (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas M D Anderson Cancer Center Department of Biostatistics Jul 22 2002

United States

Professor :: Biostatistics

Education History

University of Michigan Sep 01 1997 - May 31 2002

United States

PHD :: Biostatistics

Publications

Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, null null, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics 23 (7) (2024)
Nicholas James Short, Elias Jabbour, Nitin Jain, Jayastu Senapati, Lewis Fady Nasr, Fadi G Haddad, Zhenhua Li, Yu-Chih Hsiao, Jun J Yang, Naveen Pemmaraju, Maro Ohanian, William G Wierda, Guillermo Montalban-Bravo, Gautam Borthakur, Lina Han, Lianchun Xiao, Xuelin Huang, Regina Abramova, Min Zhao, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop Kantarjian
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia. Blood advances 8 (4) (2024)
Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics (2024)
Hagop M Kantarjian, Nicholas James Short, Fady Gh Haddad, Nitin Jain, Xuelin Huang, Guillermo Montalban-Bravo, Rashmi Kanagal-Shamana, Tapan Mahendra Kadia, Naval G Daver, Kelly Sharon Chien, Yesid Alvarado, Guillermo Garcia Manero, Ghayas C Issa, Rebecca Garris, Cedric Nasnas, Lewis Fady Nasr, Farhad Ravandi, Elias J Jabbour
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Yuexin Liu, Barrett C Lawson, Xuelin Huang, Bradley M Broom, John N Weinstein
RETRACTED: Liu et al. Prediction of Ovarian Cancer Response to Therapy Based on Deep Learning Analysis of Histopathology Images. Cancers 2023, 15 , 4044. Cancers 16 (3) (2024)
Nicholas James Short, Elias J Jabbour, Nitin Jain, Jayastu Senapati, Lewis Fady Nasr, Fadi G Haddad, Zhenhua Li, Yu-Chih Hsiao, Jun J Yang, Naveen Pemmaraju, Maro Ohanian, William G Wierda, Guillermo Montalban-Bravo, Gautam Borthakur, Lina Han, Lianchun Xiao, Xuelin Huang, Regina Abramova, Min Zhao, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop M Kantarjian
A Phase 1/2 Study of Mini-Hyper-CVD plus Venetoclax in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. Blood advances (2024)
Nicholas James Short, Naval G Daver, Courtney D D DiNardo, Tapan Mahendra Kadia, Lewis Fady Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Ghayas C Issa, Kelly Sharon Chien, Elias J Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J Stojanik, Keyur Pravinchandra Patel, Regina Abramova, Jennifer Thankachan, Marina Y Konopleva, Hagop M Kantarjian, Farhad Ravandi
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics (2024)
Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, null null, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics 23 (7) (2024)
Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics (2024)
Nicholas James Short, Naval G Daver, Courtney D D DiNardo, Tapan Mahendra Kadia, Lewis Fady Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Ghayas C Issa, Kelly Sharon Chien, Elias J Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J Stojanik, Keyur Pravinchandra Patel, Regina Abramova, Jennifer Thankachan, Marina Y Konopleva, Hagop M Kantarjian, Farhad Ravandi
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, null null, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics 23 (7) (2024)
Nicholas James Short, Naval G Daver, Courtney D D DiNardo, Tapan Mahendra Kadia, Lewis Fady Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Ghayas C Issa, Kelly Sharon Chien, Elias J Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J Stojanik, Keyur Pravinchandra Patel, Regina Abramova, Jennifer Thankachan, Marina Y Konopleva, Hagop M Kantarjian, Farhad Ravandi
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics (2024)
Yuexin Liu, Barrett C Lawson, Xuelin Huang, Bradley M Broom, John N Weinstein
RETRACTED: Liu et al. Prediction of Ovarian Cancer Response to Therapy Based on Deep Learning Analysis of Histopathology Images. Cancers 2023, 15 , 4044. Cancers 16 (3) (2024)
Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics (2024)
Nicholas James Short, Naval G Daver, Courtney D D DiNardo, Tapan Mahendra Kadia, Lewis Fady Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Ghayas C Issa, Kelly Sharon Chien, Elias J Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J Stojanik, Keyur Pravinchandra Patel, Regina Abramova, Jennifer Thankachan, Marina Y Konopleva, Hagop M Kantarjian, Farhad Ravandi
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics (2024)
Nicholas James Short, Elias Jabbour, Nitin Jain, Jayastu Senapati, Lewis Fady Nasr, Fadi G Haddad, Zhenhua Li, Yu-Chih Hsiao, Jun J Yang, Naveen Pemmaraju, Maro Ohanian, William G Wierda, Guillermo Montalban-Bravo, Gautam Borthakur, Lina Han, Lianchun Xiao, Xuelin Huang, Regina Abramova, Min Zhao, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop Kantarjian
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia. Blood advances 8 (4) (2024)
Alexandre Bazinet, Tapan M Kadia, Nicholas James Short, Gautam Borthakur, Sa A Wang, Wei Wang, Sanam Loghavi, Jeffrey L Jorgensen, Keyur Pravinchandra Patel, Courtney D D DiNardo, Naval G Daver, Yesid Alvarado, Fadi G Haddad, Sherry R Pierce, Graciela Nogueras Gonzalez, Abhishek Maiti, Koiji Sasaki, Musa Ylimaz, Phillip A Thompson, William G Wierda, Guillermo Garcia-Manero, Michael Andreeff, Elias J Jabbour, Marina Y Konopleva, Xuelin Huang, Hagop M Kantarjian, Farhad Ravandi
Undetectable Measurable Residual Disease is Associated with Improved Outcomes in AML Irrespective of Treatment Intensity. Blood advances (2023)
Sunyi Chi, Christopher R Flowers, Ziyi Li, Xuelin Huang, Peng Wei
MASH: Mediation Analysis of Survival Outcome and High-dimensional Omics Mediators with Application to Complex Diseases. bioRxiv : the preprint server for biology (2023)
Yuexin Liu, Barrett C Lawson, Xuelin Huang, Bradley M Broom, John N Weinstein
Prediction of Ovarian Cancer Response to Therapy Based on Deep Learning Analysis of Histopathology Images. Cancers 15 (16) (2023)
Nicholas J Short, Hagop Kantarjian, Farhad Ravandi, Marina Y Konopleva, Nitin Jain, Rashmi Kanagal-Shamana, Keyur Pravinchandra Patel, Walid Macaron, Tapan M Kadia, Sa Wang, Jeffrey L Jorgensen, Joseph D Khoury, Musa Ylimaz, Partow Kebriaei, Koichi Takahashi, Guillermo Garcia-Manero, Naval G Daver, Sean M Post, Xuelin Huang, Steven M Kornblau, Sara Pelletier, Wilmer Flores, Jairo Matthews, Rebecca Garris, Elias Jabbour
High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse. Blood advances 6 (13) (2022)
Can Xie, Xuelin Huang, Ruosha Li, Peter W T Pisters
A flexible-hazards cure model with application to patients with soft tissue sarcoma. Statistics in medicine 41 (29) (2022)
Yizhuo Wang, Christopher R Flowers, Ziyi Li, Xuelin Huang
CondiS web app: imputation of censored lifetimes for machine learning-based survival analysis. Bioinformatics (Oxford, England) 38 (17) (2022)
Yizhuo Wang, Bing Z Carter, Ziyi Li, Xuelin Huang
Application of machine learning methods in clinical trials for precision medicine. JAMIA open 5 (1) (2022)
Amy Trentham-Dietz, Oguzhan Alagoz, Christina Hunter Chapman, Xuelin Huang, Jinani Jayasekera, Nicolien T van Ravesteyn, Sandra J Lee, Clyde B Schechter, Jennifer M Yeh, Sylvia K Plevritis, Jeanne S Mandelblatt, null null
Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts. PLoS computational biology 17 (6) (2021)
Jing Zhang, Jing Ning, Xuelin Huang, Ruosha Li
On the time-varying predictive performance of longitudinal biomarkers: Measure and estimation. Statistics in medicine 40 (23) (2021)
Jing Ning, Chunyan Cai, Yong Chen, Xuelin Huang, Mei-Cheng Wang
Semiparametric modelling and estimation of covariate-adjusted dependence between bivariate recurrent events. Biometrics 76 (4) (2020)
Bin Shi, Peng Wei, Xuelin Huang
Functional principal component based landmark analysis for the effects of longitudinal cholesterol profiles on the risk of coronary heart disease. Statistics in medicine 40 (3) (2020)
Liyun Jiang, Fangrong Yan, Peter F Thall, Xuelin Huang
Comparing Bayesian early stopping boundaries for phase II clinical trials. Pharmaceutical statistics 19 (6) (2020)
Yayuan Zhu, Xuelin Huang, Liang Li
Dynamic prediction of time to a clinical event with sparse and irregularly measured longitudinal biomarkers. Biometrical journal. Biometrische Zeitschrift 62 (6) (2020)
Xiangyu Liu, Jing Ning, Yu Cheng, Xuelin Huang, Ruosha Li
A flexible and robust method for assessing conditional association and conditional concordance. Statistics in medicine 38 (19) (2019)
Xuelin Huang, Lei Liu, Jing Ning, Liang Li, Yu Shen
Estimation of the distribution of longitudinal biomarker trajectories prior to disease progression. Statistics in medicine 38 (11) (2019)
Xiao Lin, Ruosha Li, Fangrong Yan, Tao Lu, Xuelin Huang
Quantile residual lifetime regression with functional principal component analysis of longitudinal data for dynamic prediction. Statistical methods in medical research 28 (4) (2018)
Xiao Lin, Tao Lu, Fangrong Yan, Ruosha Li, Xuelin Huang
Mean residual life regression with functional principal component analysis on longitudinal data for dynamic prediction. Biometrics 74 (4) (2018)
Hao Liu, Xiao Lin, Xuelin Huang
An oncology clinical trial design with randomization adaptive to both short- and long-term responses. Statistical methods in medical research 28 (7) (2017)
Sangbum Choi, Liang Zhu, Xuelin Huang
Semiparametric accelerated failure time cure rate mixture models with competing risks. Statistics in medicine 37 (1) (2017)
Xuelin Huang, Fangrong Yan, Jing Ning, Ziding Feng, Sangbum Choi, Jorge Cortes
A two-stage approach for dynamic prediction of time-to-event distributions. Statistics in medicine 35 (13) (2016)
Sijin Wen, Xuelin Huang, Ralph F Frankowski, Janice N Cormier, Peter Pisters
A Bayesian multivariate joint frailty model for disease recurrences and survival. Statistics in medicine 35 (26) (2016)
Xuelin Huang, Sangbum Choi, Lu Wang, Peter F Thall
Optimization of multi-stage dynamic treatment regimes utilizing accumulated data. Statistics in medicine 34 (26) (2015)

Xuelin Huang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xuelin Huang